Concepedia

Michigan Headache and Neurological Institute

MH

200

Publications

17.1K

Citations

29

Authors

Ann Arbor

United States

Other names

MHNI

Michigan Headache and Neurological Institute is a healthcare institution in Ann Arbor, United States known for medicine, neurology, and health sciences.

HomepageROR

Top concepts

Publications

200

Botulinum Toxin Type A as a Migraine Preventive Treatment

Stephen D. Silberstein, Ninan T. Mathew, Joel R. Saper et al. · Headache The Journal of Head and Face Pain · 2000 · 540 citations · Full text

Efficacy and Safety of Topiramate for the Treatment of Chronic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Stephen D. Silberstein, Richard B. Lipton, David W. Dodick et al. · Headache The Journal of Head and Face Pain · 2007 · 499 citations

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

Richard B. Lipton, David W. Dodick, Stephen D. Silberstein et al. · The Lancet Neurology · 2010 · 452 citations

, , +9

Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

Messoud Ashina, Joel R. Saper, Roger Cady et al. · Cephalalgia · 2020 · 375 citations · Full text

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

Hong Sun, David W. Dodick, Stephen D. Silberstein et al. · The Lancet Neurology · 2016 · 357 citations

, , +5

Rows per page

1–5 of 200

Authors

29

PublicationsCitationsH-Index
JR
Joel R. Saper

Michigan Headache and Neurological Institute

207

9.5K

50

AE
Alvin E. Lake

Michigan Headache and Neurological Institute

58

1.9K

24

TR
TD Rozen

Michigan Headache and Neurological Institute

15

782

11

JS
JR Saper

Michigan Headache and Neurological Institute

20

740

9

TL
Tom Lutz

Michigan Headache and Neurological Institute

42

543

7

Rows per page

1–5 of 29